A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place. Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a … Continue reading The Anil Potti retraction record so far
Authors’ financial disclosures can be a thorny issue for scientific journals. There’s often confusion over just what should be listed as a conflict of interest, and when relationships are revealed after papers are published, lack of disclosure sometimes leads to corrections. For example, the Journal of Cell Science recently published this:
The Journal of Clinical Anesthesia has retracted a paper by a group of Israeli authors whose study may not have had appropriate ethical approval — or even collected the reported data. The article, “Accidental venous and dural puncture during epidural analgesia in obese parturients (BMI > 40 kg/m2): three different body positions during insertion,” was … Continue reading Anesthesia journal editor says “if you blow us off, it will be retracted,” and sticks to his word
If Retraction Watch was actually a business, as opposed — for the moment, anyway — to a labor of love for two guys with day jobs, 2011 would have been a very good year for business. It was a year that will probably see close to 400 retractions, including a number of high-profile ones, once … Continue reading The Year of the Retraction: A look back at 2011
The Retraction Watch category for “lack of IRB approval” as a reason for retraction — a subject we covered in our most recent Lab Times column — is growing. First there were the 90-odd retractions by Joachim Boldt, then three by Australian researchers studying Aussie-rules football players. Now, we learn that the Journal of Clinical … Continue reading Lack of ethical approval leads to JCO retraction
Careful Retraction Watch readers may have noticed that one of the categories in our right-hand column under “by reason for retraction” is “lack of IRB approval.” That’s because in just over a year, we’ve written a number of posts about two cases of retractions for that reason. One was the now-infamous case of Joachim Boldt, who has … Continue reading Should authors have to retract papers based on data obtained unethically?
Today marks the 1-year anniversary of the launch of Retraction Watch. We’d like to thank our readers, tipsters, and fans for your support and feedback — and our helpful critics who have spurred us to do better. Over the past 12 months we’ve written more than 250 posts about retractions ranging from the extraordinary — think … Continue reading Happy anniversary, Retraction Watch: What we’ve learned, and what’s in store for year two
If there’s any group of subjects a scientist wouldn’t want to piss off, it would have to be Aussie-rules football and rugby players, who are tough enough to make a saltwater crocodile wish it was a belt. And when those guinea pigs are suffering from low back pain — well, we shudder to think. The … Continue reading A dingo ate my IRB form: Journal cries foul over Aussie-rules football and rugby papers that lied
Flawed research that leads to retractions is a problem for editors, publishers and the scientific community. But what about patients? In a recent issue of the Journal of Medical Ethics, R. Grant Steen asks the question — and answers it in the affirmative. We’ve heard from Steen before; he has written two recent papers on … Continue reading No academic matter: Study links retractions to patient harm
We’ve both been at conferences — Adam at the Society of Cardiovascular Anesthesiologists in Savannah, and Ivan at the Council of Science Editors in Baltimore, where he’ll be on a panel today about finding fraud — so we haven’t had a lot of time to run down retractions. But there were a few retraction-related developments … Continue reading Roundup: A new record? And paper retracts story about Canadian Paxil researcher-turned pol Kutcher